DRMADermata Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Dermata Therapeutics, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DRMA본 종목 | $3M#5 | — | 0.9x#8 | — | — | 38.5%#5 | — | -216.7%#7 | — | — | -77.8%#4 | — |
| GRI | $3M#1 | — | 0.3x#4 | — | -100.0%#8 | -45.7%#11 | — | -116.3%#5 | — | — | -96.7%#9 | — |
| KALA | $3M#2 | 0.0x#2 | 0.4x#5 | — | — | 29.9%#6 | — | -298.3%#9 | -69.9%#1 | — | -99.5%#11 | — |
| ERNA | $3M#3 | 0.0x#5 | 1.0x#9 | 5.6x#6 | 755.9%#1 | 68.4%#4 | -1601.2%#5 | -440.1%#11 | -1016.2%#4 | — | -95.8%#8 | — |
| SXTP | $3M#4 | — | 1.2x#10 | 3.2x#5 | 65.5%#2 | 7.3%#7 | -771.6%#3 | -281.7%#8 | -163.8%#3 | 6#1 | -83.3%#5 | — |
| PTPI | $3M#6 | 0.1x#6 | 3.8x#11 | 0.5x#2 | -12.2%#4 | 113.4%#1 | -90.8%#2 | 273.0%#1 | — | — | -50.7%#2 | — |
| BFRGW | $3M#7 | — | 0.4x#6 | 22.2x#7 | — | 7.1%#8 | -5652.4%#7 | -93.0%#2 | -5287.3%#6 | — | -72.6%#3 | — |
| APVO | $3M#8 | 0.0x#3 | 0.4x#7 | 0.8x#3 | -74.7%#6 | -7.6%#9 | -845.0%#4 | -429.8%#10 | — | — | -95.0%#6 | — |
| ZVSA | $2M#9 | — | — | — | — | -165.1%#13 | — | — | — | — | — | — |
| HCWB | $2M#10 | 0.0x#4 | 0.3x#3 | 39.6x#8 | -97.9%#7 | 73.5%#3 | -24270.7%#8 | -107.2%#4 | -99.4%#2 | 3#2 | -95.1%#7 | — |
| BIVIW | $2M#11 | — | 0.2x#2 | — | — | -25.8%#10 | — | -214.9%#6 | -1671.2%#5 | — | -19.7%#1 | — |
| ONCO | $2M#12 | 0.0x#1 | 0.2x#1 | 2.5x#4 | -67.7%#5 | 76.1%#2 | -2190.0%#6 | -104.2%#3 | — | — | -99.7%#12 | — |
| KPTI | $2M#13 | — | — | 0.0x#1 | 0.6%#3 | -156.5%#12 | -62.1%#1 | — | — | — | -98.5%#10 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-11-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice